Pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosures of Related Party Transactions for the half year ended September 30, 2022.

Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th November, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the following businesses: a) Unaudited Financial Results (Consolidate & Standalone) for the Second quarter and half year ended on 30th September 2022. b) Any Other Item. The Meeting was started at 10.30 am and concluded on 12:15 pm.

Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th November, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the following businesses: a) Unaudited Financial Results (Consolidate & Standalone) for the Second quarter and half year ended on 30th September 2022.

Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 04th November, 2022, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the following businesses: a) Unaudited Financial Results (Consolidate & Standalone) for the Second quarter and half year ended on 30th September 2022. b) Any Other Item.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Monday, 7th November, 2022 at 4.00 p.m. (IST) for discussing the Un-audited Financial Results of the Company for the quarter ended 30th September, 2022. Link for joining, Dial in and other details of the call are enclosed herewith. ICICI Securities Limited through its representatives along with Company's officials will coordinate the aforesaid meeting.

POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2022 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, the 4th November, 2022, inter alia to consider the following: a) To consider and approve the Standalone and Consolidated Un-Audited Financial Results of the Company for the Second quarter and half year ended on 30th September, 2022. b) To transact any other matter which the Board may deem fit.

In terms of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we enclose herewith confirmation certificate received from M/s Mas Services Limited, Registrar & Share Transfer Agent of the Company for the quarter ended 30th September, 2022. Request to take the same in your records and oblige.

It may please be noted that in compliance with the SEBI (Prohibition to Insider Trading) Regulations, 2015 as amended by the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 read with clarification given by BSE Circular Ref No.: LIST/COMP/01/2019-20 dated 02.04.2019 and NSE letter ref no: NSE/CML/2019/11 dated 02.04.2019 read with Company''s Code of Conduct for prevention of Insider Trading, the Trading Window of the Company has been kept closed for designated person from Saturday, the 1st October, 2022 till the end of 48 hours after the declaration of Financial Results for the quarter and half-year ended on 30th September, 2022